+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multicenter, placebo-controlled trial of alternate-day prednisone or daily omega-3 fatty acids in children and young adults with IgA nephropathy Report from the Southwest Pediatric Nephrology Study Group



Multicenter, placebo-controlled trial of alternate-day prednisone or daily omega-3 fatty acids in children and young adults with IgA nephropathy Report from the Southwest Pediatric Nephrology Study Group



Journal of the American Society of Nephrology 14(Abstracts Issue): 751A




(PDF emailed within 1 workday: $29.90)

Accession: 035349979

Download citation: RISBibTeXText


Related references

Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group. Clinical Journal of the American Society of Nephrology 1(3): 467-474, 2007

A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study. American Journal of Kidney Diseases 26(5): 792-796, 1995

A multicenter study of IgA nephropathy in children. A report of the Southwest Pediatric Nephrology Study Group. Kidney International 22(6): 643-652, 1982

Multicenter trial of mycophenolate mofetil in children with steroid dependent or frequent relapsing nephrotic syndrome Report of the Southwest Pediatric Nephrology Study Group. Journal of the American Society of Nephrology 14(Abstracts Issue): 751A, 2003

Prognosis of children with iga nephropathy igan report of the southwest pediatric nephrology study group. Kidney International 31(1): 202, 1987

Prognostic indicators in children with IgA nephropathy: Report of the Southwest Pediatric Nephrology Study Group. Pediatric Nephrology 8(1): 15-20, 1994

A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism. Molecular Autism 6: 18, 2015

Vesicoureteric reflux vur in infants and young children report of the southwest pediatric nephrology study group. Kidney International 33(1): 179, 1988

Renal transplant outcome with cyclosporine and prednisone immunosuppression in 73 pediatric recipients a report of the southwest pediatric nephrology study group usa. Pediatric Research 20(4 PART 2): 447A, 1986

A randomized placebo controlled double blind trial of cyclosporine in steroid resistant idiopathic focal segmental glomerulosclerosis in children A report of the New York, New Jersey Pediatric Nephrology Collaborative Study Group. Journal of the American Society of Nephrology 4(3): 289, 1993

Long term 3 5y outcome of 103 first renal transplants tx in a pediatric population treated with cyclosporin csa and prednisone pred a report of the southwest pediatric nephrology study group. Kidney International 37(1): 603, 1990

Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. Journal of Attention Disorders 12(5): 394-401, 2008

Glomerular filtration rate in children with advanced chronic renal failure during short term therapy with growth hormone A multicenter trial of the Southwest Pediatric Nephrology Study Group. Journal of the American Society of Nephrology 5(3): 326, 1994

Reductions of intimate partner violence resulting from supplementing children with omega-3 fatty acids: A randomized, double-blind, placebo-controlled, stratified, parallel-group trial. Aggressive Behavior 2018, 2018

Association of IgA nephropathy with steroid-responsive nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. American Journal of Kidney Diseases 5(3): 157-164, 1985